Trial Profile
Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 May 2014
Price :
$35
*
At a glance
- Drugs AL 37807 (Primary) ; Latanoprost
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Therapeutic Use
- Sponsors Alcon
- 14 May 2014 New trial record